ATE239698T1 - Angiogenese hemmer - Google Patents

Angiogenese hemmer

Info

Publication number
ATE239698T1
ATE239698T1 AT99106760T AT99106760T ATE239698T1 AT E239698 T1 ATE239698 T1 AT E239698T1 AT 99106760 T AT99106760 T AT 99106760T AT 99106760 T AT99106760 T AT 99106760T AT E239698 T1 ATE239698 T1 AT E239698T1
Authority
AT
Austria
Prior art keywords
angiogenesis inhibitors
angiogenesis
inhibitors
Prior art date
Application number
AT99106760T
Other languages
English (en)
Inventor
Chiho Fukiage
Mitsuyoshi Azuma
Jun Rui Inoue
Masayuki Nakamura
Yuka Yoshida
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE239698T1 publication Critical patent/ATE239698T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99106760T 1995-10-25 1996-10-23 Angiogenese hemmer ATE239698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27748595 1995-10-25
JP24804696 1996-09-19

Publications (1)

Publication Number Publication Date
ATE239698T1 true ATE239698T1 (de) 2003-05-15

Family

ID=26538555

Family Applications (3)

Application Number Title Priority Date Filing Date
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor
AT99102501T ATE230389T1 (de) 1995-10-25 1996-10-23 Angiogenese inhibitoren
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor
AT99102501T ATE230389T1 (de) 1995-10-25 1996-10-23 Angiogenese inhibitoren

Country Status (13)

Country Link
US (2) US6057290A (de)
EP (2) EP0927716B1 (de)
AR (1) AR004694A1 (de)
AT (3) ATE230275T1 (de)
AU (1) AU716495B2 (de)
BR (1) BR9605267A (de)
CA (1) CA2188817C (de)
DE (3) DE69628050T2 (de)
ES (2) ES2190139T3 (de)
HU (1) HUP9602943A3 (de)
MX (1) MX9605156A (de)
NO (1) NO964514L (de)
PL (1) PL316669A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0838460A4 (de) * 1995-07-13 1998-11-04 Senju Pharma Co Piperazinderivate und ihre anwendung
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
ES2201524T3 (es) * 1997-09-04 2004-03-16 Nippon Chemiphar Co., Ltd. Derivados de epoxisuccinamida.
US6015787A (en) * 1997-11-04 2000-01-18 New England Medical Center Hospitals, Inc. Cell-permeable protein inhibitors of calpain
KR20010041605A (ko) * 1998-03-05 2001-05-25 요시다 쇼지 안저 조직 세포병리와 관련된 질환의 예방 및 치료용 제약조성물
EP1064021B1 (de) 1998-03-20 2004-09-08 Senju Pharmaceutical Co., Ltd. Verwendung von cysteinprotease inhibitoren zur herstellung eines arzneimittels zur vorgbeugung und behandlung von gehirngewebezerrütung infolge hypertensive enzephalopathie oder encephalothlipsis
GB9819860D0 (en) * 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
DE69930764D1 (de) 1998-12-23 2006-05-18 G D Searle Llc St Louis Verwendung von cyclooxygenase-2 inhibitor celecoxib und capecitabine zur kombinationsbehandlung von neoplasia
WO2000058280A1 (fr) * 1999-03-26 2000-10-05 Shionogi & Co., Ltd. Derives de sulfonamide carbocyclique
KR20010001270A (ko) * 1999-06-03 2001-01-05 복성해 혈관신생을 억제하는 새로운 이소쿠마린 유도체
WO2001026648A1 (fr) 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee
AU1735001A (en) * 1999-12-10 2001-06-18 Senju Pharmaceutical Co., Ltd. Cyclodextrin-containing pharmaceutical composition
AU2001292287A1 (en) * 2000-10-26 2002-05-06 Senju Pharmaceutical Co. Ltd. Drug composition comprising dipeptydyl aldehyde derivative
AU2002221066A1 (en) * 2000-12-12 2002-06-24 Senju Pharmaceutical Co. Ltd. Hydrazone derivatives and use thereof in medicines
CZ20033296A3 (cs) * 2001-06-06 2004-04-14 Eli Lilly And Company Benzoylsulfonamidy a sulfonylbenzamidiny jako protinádorové sloučeniny
US7115607B2 (en) * 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
WO2003078415A1 (fr) * 2002-03-15 2003-09-25 Senju Pharmaceutical Co., Ltd. Derive de l'hemiacetal cyclique et son utilisation
EP1491537B1 (de) * 2002-03-29 2010-07-07 Senju Pharmaceutical Co., Ltd. Hydroxymorpholinonderivat und dessen medizinische verwendung
EP1354586A1 (de) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH Verwendung von Hydroxypyridon Derivaten zur Wundheilung
AU2003248059A1 (en) 2002-07-22 2004-02-09 Senju Pharmaceutical Co., Ltd. NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
GB0314262D0 (en) 2003-06-19 2003-07-23 Univ Nottingham Trent Novel compounds and methods of using the same
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
JPWO2011105070A1 (ja) 2010-02-25 2013-06-20 パナソニック株式会社 需給制御装置、需給制御方法、およびプログラム
EP2593089B1 (de) 2010-07-14 2018-04-04 Senju Pharmaceutical Co., Ltd. Feste dispersion eines alfa-ketoamid-derivats
GB201218084D0 (en) * 2012-10-09 2012-11-21 Univ Aston Novel compounds and methods for use in medicine
GB201220474D0 (en) * 2012-11-14 2012-12-26 Sagetis Biotech Sl Polypeptides
WO2019217410A1 (en) * 2018-05-07 2019-11-14 Neuro Theranostics, Inc. Compositions and methods for treating traumatic brain injury
US20240150396A1 (en) * 2021-03-03 2024-05-09 The Texas A&M University System Inhibitors of cysteine proteases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50137951A (de) 1974-04-27 1975-11-01
JPS5754157A (en) 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
JP2536754B2 (ja) * 1987-05-08 1996-09-18 日本ケミファ株式会社 ピペラジン誘導体
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
JP2701932B2 (ja) 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
US5510531A (en) 1989-04-10 1996-04-23 Suntory Limited Proteinase inhibitor
DE69024400T2 (de) * 1989-04-28 1996-06-27 Takara Shuzo Co Dem menschlichen Calpastatin ähnliches Polypeptid
ZA921279B (en) 1991-02-22 1993-08-23 Du Pont Merck Pharma Substituted alpha-aminoaldehydes and derivatives
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
JP2848232B2 (ja) 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
US5607831A (en) 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death
US5658885A (en) 1993-04-27 1997-08-19 The Dupont Merck Pharmaceutical Company Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
WO1996010014A1 (en) * 1994-09-27 1996-04-04 Takeda Chemical Industries, Ltd. Aldehyde derivatives as upsteine protease inhibitors
US5614649A (en) 1994-11-14 1997-03-25 Cephalon, Inc. Multicatalytic protease inhibitors
EP0731107A1 (de) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Herstellung von Aldehyd-Derivaten
JPH11505532A (ja) 1995-05-10 1999-05-21 カイロサイエンス・リミテッド 金属プロテアーゼとｔｎｆの放出を抑制するペプチド化合物およびその治療的使用
EP0838460A4 (de) * 1995-07-13 1998-11-04 Senju Pharma Co Piperazinderivate und ihre anwendung
KR100490807B1 (ko) 1995-11-28 2005-10-14 세파론, 인코포레이티드 시스테인및세린프로테아제의d-아미노산함유억제제

Also Published As

Publication number Publication date
AU7038496A (en) 1997-05-01
US6551999B1 (en) 2003-04-22
EP0927716A1 (de) 1999-07-07
ES2190139T3 (es) 2003-07-16
NO964514L (no) 1997-04-28
US6057290A (en) 2000-05-02
EP0771565A3 (de) 1998-11-04
DE69625622D1 (de) 2003-02-06
PL316669A1 (en) 1997-04-28
DE69625575T2 (de) 2003-09-25
ES2193615T3 (es) 2003-11-01
ATE230275T1 (de) 2003-01-15
EP0771565A2 (de) 1997-05-07
EP0927716B1 (de) 2003-05-07
DE69625575D1 (de) 2003-02-06
DE69625622T2 (de) 2003-08-14
DE69628050D1 (de) 2003-06-12
BR9605267A (pt) 1998-07-21
AR004694A1 (es) 1999-03-10
HUP9602943A2 (en) 1997-08-28
ATE230389T1 (de) 2003-01-15
CA2188817A1 (en) 1997-04-26
AU716495B2 (en) 2000-02-24
CA2188817C (en) 2010-01-26
DE69628050T2 (de) 2004-04-01
HUP9602943A3 (en) 1998-03-02
MX9605156A (es) 1998-05-31
NO964514D0 (no) 1996-10-24
EP0771565B1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
ATE239698T1 (de) Angiogenese hemmer
PT846422E (pt) Formula infantil anti-regurgitacao
ID16345A (id) Senyawa-senyawa heterosiklik
DE59609887D1 (de) Substituierte cyanophenyluracile
DE69621066D1 (de) Bohrloch-Zementierungswerkzeug
PT858464E (pt) Inibidores de trombina
DE69630414D1 (de) 5B4T-Kodierungsschema
EE9800172A (et) Ühendid
DE59610332D1 (de) Substituierte aminouracile
DE69620627T2 (de) Polyfluoralkyl-tryptiphan tripeptid thrombin hemmer
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
BR9610514A (pt) Inibidores cicloantihelmínticos
DE59607958D1 (de) Substituierte phenyluracile
EE9700222A (et) Profileerimisseade
ATA51495A (de) Schubkastenauszug
KR970007845U (ko) 작업양말
KR970020492U (ko) 보조용 양말
IT235743Y1 (it) Stendibiancheria
KR970016047U (ko) 다다미 침대
KR960036162U (ko) 다다미가 설치된 침대
BR7500419U (pt) Varal
KR970039372U (ko) 빨랫줄

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties